GlassScriptPhysician profile
Megan M Walker
NPI 1750331161
$4,856.69
in general payments reported to CMS, 2019-2025
19 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what 93% of Low Vision Rehabilitation providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $170 · 2021: $353 · 2022: $689 · 2023: $637 · 2024: $1,278 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,079.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,781.75 | 2019-2025 | Total30, Precision7, Tryptyr |
| Bausch & Lomb Americas INC. | $952.11 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $361.06 | 2019-2023 | |
| Abbvie INC. | $283.73 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $273.57 | 2024-2025 | Xdemvy |
| Allergan, INC. | $167.11 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $156.41 | 2021-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $126.04 | 2019-2024 | |
| Pharming Healthcare, INC. | $124.99 | 2019 | |
| Shire North American Group INC | $116.88 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $108.36 | 2019 | |
| Dompe US, INC. | $107.98 | 2022-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $85.92 | 2021-2022 | |
| Oyster Point Pharma, INC. | $85.67 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $35.97 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $30.79 | 2021-2023 | Myday Contact Lens |
| Carl Zeiss Meditec, INC. | $20.51 | 2020 | |
| Amgen INC. | $19.86 | 2024 | Tepezza |
| Biotissue Holdings INC. | $17.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.